Editorial & Opinion

Reply to Chen et al. : Reexamining Chronic Obstructive Pulmonary Disease in Bronchiectasis: Elucidating Overdiagnosis and Outcomes from EMBARC's ROSE Criteria.

التفاصيل البيبلوغرافية
العنوان: Reply to Chen et al. : Reexamining Chronic Obstructive Pulmonary Disease in Bronchiectasis: Elucidating Overdiagnosis and Outcomes from EMBARC's ROSE Criteria.
المؤلفون: Chalmers JD; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom., De Soyza A; Population and Health Science Institute, Newcastle University and National Institute for Health and Care Research Biomedical Research Centre for Ageing, Freeman Hospital, Newcastle, United Kingdom., Aliberti S; Respiratory Unit, Scientific Institutes of Hospitalization and Care Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Polverino E; Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Vall d'Hebron Barcelona Hospital Campus, Biomedical Research Centre, Barcelona, Spain; and.; Thorax Institute, Institute of Biomedical Research August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
المصدر: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Jul 15; Vol. 210 (2), pp. 248-249.
نوع المنشور: Letter; Comment
اللغة: English
بيانات الدورية: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
أسماء مطبوعة: Publication: 2000- : New York, NY : American Thoracic Society
Original Publication: New York, NY : American Lung Association, c1994-
مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/diagnosis , Pulmonary Disease, Chronic Obstructive*/physiopathology , Pulmonary Disease, Chronic Obstructive*/complications , Bronchiectasis*/diagnosis , Bronchiectasis*/epidemiology , Medical Overuse*/statistics & numerical data, Humans
التعليقات: Comment on: Am J Respir Crit Care Med. 2024 Jul 15;210(2):247-248. doi: 10.1164/rccm.202402-0289LE. (PMID: 38579279)
References: Lancet Respir Med. 2023 Jul;11(7):637-649. (PMID: 37105206)
Lancet Respir Med. 2019 Mar;7(3):213-226. (PMID: 30658914)
Am J Respir Crit Care Med. 2022 Aug 15;206(4):417-426. (PMID: 35436182)
Am J Respir Crit Care Med. 2024 Jul 1;210(1):119-127. (PMID: 38271696)
Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85. (PMID: 24328736)
ERJ Open Res. 2021 Nov 22;7(4):. (PMID: 34820447)
تواريخ الأحداث: Date Created: 20240405 Date Completed: 20240715 Latest Revision: 20240801
رمز التحديث: 20240801
مُعرف محوري في PubMed: PMC11273317
DOI: 10.1164/rccm.202403-0476LE
PMID: 38579281
قاعدة البيانات: MEDLINE
الوصف
تدمد:1535-4970
DOI:10.1164/rccm.202403-0476LE